Pathophysiology of Acute Liver Failure.
Dong V, Nanchal R, Karvellas CJ.
Nutr Clin Pract. 2020 Feb;35(1):24-29. doi: 10.1002/ncp.10459. Epub 2019 Dec 15.
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.
Armenian P, Vo KT, Barr-Walker J, Lynch KL.
Neuropharmacology. 2018 May 15;134(Pt A):121-132. doi: 10.1016/j.neuropharm.2017.10.016. Epub 2017 Oct 14.
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.
Ciccarone D.
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
Naloxone.
Handal KA, Schauben JL, Salamone FR.
Ann Emerg Med. 1983 Jul;12(7):438-45. doi: 10.1016/s0196-0644(83)80343-6.
Fentanyl crisis in Europe and Switzerland: current situation and response.
Iuga R, Robet T, Favrod-Coune T, Khazaal Y, Penzenstadler L, Zullino D.
Rev Med Suisse. 2025 Jun 4;21(921):1166-1168. doi: 10.53738/REVMED.2025.21.921.47325.
Blood concentrations of new synthetic opioids.
Adamowicz P, Nowak K.
Int J Legal Med. 2022 Jan;136(1):107-122. doi: 10.1007/s00414-021-02729-2. Epub 2021 Oct 22.
Designer drugs – still a threat?
Rozenek EB, Wilczyńska K, Górska M, Waszkiewicz N.
Przegl Epidemiol. 2019;73(3):337-347. doi: 10.32394/pe.73.23.
Newly Emerging Drugs of Abuse.
Tamama K, Lynch MJ.
Handb Exp Pharmacol. 2020;258:463-502. doi: 10.1007/164_2019_260.
[New psychoactive substances in emergency medicine].
Marinowitz R, Strube J, Schaper A.
Nervenarzt. 2024 Jan;95(1):28-34. doi: 10.1007/s00115-023-01602-4. Epub 2024 Jan 8.
[Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
Strube J, Schaper A.
Med Klin Intensivmed Notfmed. 2019 Nov;114(8):684-692. doi: 10.1007/s00063-018-0405-2. Epub 2018 Feb 5.
